This study describes the safety of a hybrid closed-loop insulin delivery system among patients with type 1 diabetes.
This Medical Letter review summarizes a sensor-augmented insulin pump that automatically stops delivery of insulin based on interstitial glucose levels in patients with type 1 diabetes.
To determine whether sensor-augmented insulin pump with automated low-glucose suspension helps patients with type 1 diabetes avoid hypoglycemic events, Ly and coauthors conducted a randomized trial in which 46 patients with impaired hypoglycemia awareness used the sensor-augmented insulin pump and 49 used a standard insulin pump.
Wallia and Molitch review currently available insulin therapy, as well as evidence on the use, application, initiation, and intensification of insulin in the outpatient setting.
This randomized clinical trial compares the effects of hydrocortisone vs placebo on development of septic shock among intensive care patients with severe sepsis who were not in septic shock.